Overview

Study of the Use of Favipiravir in Hospitalized Subjects With COVID-19

Status:
Completed
Trial end date:
2020-10-30
Target enrollment:
Participant gender:
Summary
To determine the effect of favipiravir + SOC v. SOC on COVID-19 viral clearance.
Phase:
Phase 2
Details
Lead Sponsor:
Fujifilm Pharmaceuticals U.S.A., Inc.
Treatments:
Favipiravir